Recordati Rare Company Profile

« Back to Dashboard

What is the competitive landscape for RECORDATI RARE, and what generic alternatives to RECORDATI RARE drugs are available?

RECORDATI RARE has eight approved drugs.

There are three US patents protecting RECORDATI RARE drugs.

There are twelve patent family members on RECORDATI RARE drugs in six countries.

Summary for Applicant: Recordati Rare

International Patents:	12
US Patents:	3
Tradenames:	9
Ingredients:	8
NDAs:	8

ADD ALERT

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Exclusivity Expiration
Recordati Rare	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-008	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-006	Approved Prior to Jan 1, 1982		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	INDOCIN	indomethacin sodium	INJECTABLE;INJECTION	018878-001	Jan 30, 1985	AP	RX	Yes	Yes	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	DESOXYN	methamphetamine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	005378-003	Approved Prior to Jan 1, 1982		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	COSMEGEN	dactinomycin	INJECTABLE;INJECTION	050682-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	DESOXYN	methamphetamine hydrochloride	TABLET;ORAL	005378-002	Approved Prior to Jan 1, 1982	AA	RX	Yes	Yes	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	CHEMET	succimer	CAPSULE;ORAL	019998-002	Jan 30, 1991		RX	Yes	Yes	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	PEGANONE	ethotoin	TABLET;ORAL	010841-003	Approved Prior to Jan 1, 1982		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	TRANXENE SD	clorazepate dipotassium	TABLET;ORAL	017105-004	Approved Prior to Jan 1, 1982		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Recordati Rare	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-002	Approved Prior to Jan 1, 1982		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Recordati Rare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Recordati Rare	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-007	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Recordati Rare	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Recordati Rare	TRANXENE SD	clorazepate dipotassium	TABLET;ORAL	017105-004	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Recordati Rare	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-003	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Recordati Rare	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-006	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Recordati Rare	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-008	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Recordati Rare	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-002	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Recordati Rare	TRANXENE SD	clorazepate dipotassium	TABLET;ORAL	017105-005	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for RECORDATI RARE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
ibuprofen lysine	Injection	10 mg/mL, 2 mL vial	NEOPROFEN	10/1/2010

International Patent Family for Recordati Rare Drugs

Country	Document Number	Estimated Expiration
Mexico	PA01011629	► Subscribe
Canada	2361160	► Subscribe
Austria	318136	► Subscribe
European Patent Office	1205181	► Subscribe
Germany	60209269	► Subscribe
European Patent Office	1249234	► Subscribe
Germany	60110185	► Subscribe
Japan	2002193799	► Subscribe
Japan	2002326929	► Subscribe
Canada	2377453	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

Recordati Rare

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

DrugPatentWatch Database Preview

Recordati Rare Company Profile

« Back to Dashboard

Summary for Applicant: Recordati Rare

Glossary

Expired Patents for Recordati Rare

Paragraph IV activity for RECORDATI RARE drugs

International Patent Family for Recordati Rare Drugs

Similar Applicant Names

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Get our Free Drug Patent Bulletin